Respiratory Immunopharmacology
21 – 30 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses
(
- Contribution to journal › Article
-
Mark
Mast cell tryptase enhances wound healing by promoting migration in human bronchial epithelial cells
(
- Contribution to journal › Article
-
Mark
Lung transplant after 6 months on ECMO support for SARS-CoV-2-induced ARDS complicated by severe antibody-mediated rejection
(
- Contribution to journal › Article
-
Mark
Efficacy of mepolizumab in usual clinical practice and characteristics of responders : Mepolizumab in usual clinical practice
(
- Contribution to journal › Article
- 2020
-
Mark
Early career members at the ers lung science conference 2020 : Metabolic alterations in lung ageing and disease
(
- Contribution to journal › Article
-
Mark
Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells
(
- Contribution to journal › Article
-
Mark
Longitudinal Imaging Using PET/CT with Collagen-I PET-Tracer and MRI for Assessment of Fibrotic and Inflammatory Lesions in a Rat Lung Injury Model
(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
(
- Contribution to journal › Article
-
Mark
Imiquimod: ett nytt potentiellt läkemedel för COVID19?
(
- Contribution to conference › Abstract
-
Mark
No gender-related bias in COPD diagnosis and treatment in Sweden : a randomised, controlled, case-based trial
(
- Contribution to journal › Article